Latest News
Xpeng To Lead Autonomous Driving In China? Is XPEV Undervalued?
Key points: Xpeng is a critical play in the Chinese EV market, but could be a leader for autonomous driving The company has a diverse range of autonomous offerings, including the
Petco (WOOF) Affirm FY22 Guidance, CEO Cites Steep Growth Trajectory
Key points: Petco reaffirm FY guidance ahead of today's investor day CEO Ron Coughlin claims company is on the 'steepest growth trajectory in all of retail' Petco's
Zentek Ltd Stock Soared 150%+ After Nasdaq Uplisting. Should You Buy It?
Key points: Zentek stock soared 150%+ after being upgraded to the Nasdaq market. In addition, the company’s shares were upgraded from the OTC markets. Investors chee
Valirx Shares Plunged 20.8% on Licensing Delays for Its VAL201 Drug
Key points: Valirx shares plunged 20.8% on delays in sub-licensing its VAL201 drug. The licensing company TheoremRx is yet to secure funding for the project. Investo
Creative Realities, CREX, Stock Up 60% On Results – More To Come?
Key points: Creative Realities announced annual results and they moved into profit The stock jumped 60% premarket on the news The big question is what happens next?
Why Has Beowulf Fallen On Kallak Concession Award? It’s The Details
Key points: Beowulf shares jumped yesterday on the Kallak North Concession Award Beowulf has fallen back 20% today - why? It’s in the details of the licence that was award
Futura Medical (FUM) Shares Surged 16.2% on Korean Supply Deal. Is It a Buy?
Key points: Futura Medical shares surged 16.2% on the Korean supply agreement. The company has partnered with Menarini Korea to market its ED drug. Menarini will ens
Why Have RWS Shares Slumped 26% On Liones Takeover News?
Key points: RWS Holdings shares have dropped 26% this morning This is as they announce the takeover of Liones Holding The fall though is a result of predictions of lower g
4D Pharma (DDDD) Shares Soared 36.8% As Phase II Study Met Endpoints. What’s Next?
Key points: The 4d Pharma share price soared 36.8% on positive clinical trial results. The biotech firm reported upbeat results for its MRx0518-Keytruda study. The o
Capital Metals, CMET, Drops 6% On Project Update – Why?
Key points: Capital Metals has updated on its Sri Lanka mineral sands project Capital shares fell 6% on the back of the news Why, is there something wrong with the pro
Uncertainty at Turtle Beach, Time For Buyout or Management Overhaul?
Key points: Donerail issues letter to shareholders regarding new board nomination A buyout deal could be on the table in a matter of weeks, spurring a 7.5% stock gain
Carnival Corp Misses on Q1 Earnings, Predicts Annual Loss on Fuel Hike
Key points: Carnival Corp recorded an EPS of -$1.66 and revenue of $1.62B, falling short of expectations Just as post-covid travel optimism gained traction, the Ukraine conflict
Gevo (GEVO) Stock Rallies 17% On Sustainable Fuel Deal With Delta
Key points: Gevo signs seven-year agreement with Delta for 75M gallons of SAF per year The company expects the deal to bring in $2.8B of revenue, sending GEVO stock soaring 17%
Palisade Bio Stock Spiked 90% on FDA Letter To Proceed. Is It a Buy?
Key points: Palisade Bio stock spiked 90% higher on a letter to proceed from the FDA. The company is working on a drug to restore bowel movement after surgery. PALI
Toyota Partners With ChargePoint, Is CHPT Stock Finally Rising?
Key points: Toyota partners with ChargePoint to offer customers a range of EV charging capabilities CHPT stock opened with a loss of 0.5% before gaining slightly, investors are s
Kaixin Auto Stock Rallied 43% on 5,000 EV Trucks Order. What’s Next?
Key points: Kaixin Auto’s stock price rallied 43% on a 5,000 logistics vehicles order. The move marks a significant milestone for Kaixin Auto’s transformation. Kaixi
The Draganfly Stock Soared 105% on a Massive Ukraine Drone Order. Is It a Buy?
Key points: Draganfly's stock soared 105% after receiving an order for up to 200 drones. The drones are for use in Ukraine as the war with Russie continues. Investor
Nike Jumps 6% on Q3 Beat But Holds Off On FY Guidance, What’s Next?
Key points: For Q3, Nike reported an EPS of $0.87 per share and revenue of $10.87B, topping estimates Amid global uncertainty and consumer backlash in China, Nike are holding off
Smart For Life, SMFL, Leaps 58% Premarket – Why?
Key points: Smart for Life sells, essentially, babies’ rusks as a diet Given modern nutrition this might actually work SMFL is a new float on NASDAQ and hasn’t done well s
Kanabo (KNB) Shares Have Fallen 52.7% in 2022. Have They Bottomed?
Key points: Kanabo shares have fallen 52.7% in 2022, but have they bottomed? The shares may be ready to rally after forming a bottoming pattern. The cannabis company